newsletter3

banner-about

Press Room

Meet us at DASEM Emergency Conference in Denmark

Denmark, April 20, 2017.

Meet us at Emergency Conference DASEM in Denmark on April 28-29, 2017.

DASEM is the annual meeting of the Danish Society for Emergency Medicine, this year held in Middelfart, Denmark.

DASEM logo

See the suPAR posters during the posterwalk and presentation on April 29 at 11.00 - 11.45:

"suPAR is associated with risk of future acute sugery and post-operative mortality in acutely admitted medical patients"  by Jeppe Meyer and

"suPAR is also a strong predictor of mortality for the young acute medical patient"
by Line Jee Hartmann Rasmussen.

Visit our booth no. 3 where we will be running demos of the suPARnostic® Quick Triage product during the coffee and lunch breaks!

Please find more information on the program here; DASEM 2017

Meet us at SWEET 2017 in Stockholm

Denmark, March 15, 2017.

Meet us at SWEET 2017 in Stockholm on March 23-24, 2017.

SWEET is the National Meeting for the Swedish Society of Emergency Medicine.

Please find more information on the program heresweetlogo

Visit us at the ViroGates booth where we will be running demos of the suPARnostic® Quick Triage product during the coffee breaks, together with our distributor Triolab!

 

ViroGates at Conferences in 2017

To see a full list of Conferences and Congresses where ViroGates will be present with suPARnostic® in 2017 - please have a look under Events here

suPAR data from Acute Care published in Emergency Medicine Journal

Denmark, January 23, 2017.

The article “suPAR in Acute Care: A strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study” was recently published in Emergency Medicine Journal.

The study included 4343 consecutively admitted patients from the AMU at a large Danish university hospital (Hvidovre).

The conclusion is again, that in an unselected population of acute medical patients;
"A high suPAR level upon admission to the AMU is a marker of severe disease and increased risk of readmission and mortality after adjusting for all other risk factors .... and suPAR adds information to established prognostic indicators".

Patients with low suPAR levels have low risk of readmission and mortality, while patients with high suPAR levels have a high risk of adverse events.

Please find the publication by Line J.H.Rasmussen et al from EMJ here

 BMJ EMJ pubcover

suPARnostic® Quick Triage Test now even faster

Denmark, Januray 9, 2017.

The suPARnostic® Quick Triage Test is now even more quick, as the plasma sample only has to be centrifuged for 1 minute for normal blood collection tubes (10 minutes for plasma preparation tubes).

This means that the quantitative result of the Quick TriageTest is now available in approx. 20 minutes, making this a perfect solution for the Emergency Room where a fast result is required, and can even be done without use of the clinical laboratory!

More information on the suPARnostic® Quick Triage product hereTil supartesting2

 

 

suPAR abstract wins 1. prize at DEMC7 Emergency Conference

Denmark, December 1, 2016.

The abstract "suPAR as a standard prognostic test in the Acute Medical Unit at Hvidovre Hospital" was selected for an oral presentation, and won 1. prize at DEMC7 in Copenhagen, the biggest Emergency Medicine Conference in northern Europe, on November 25.

Line Jee Hartmann Rasmussen from Hvidovre Hospital presented her data  on 17.312 acute medical patients measured with suPAR, to verify the prognostic value of suPAR with regard to readmission and survival.

The conclusion is, that high suPAR was associated with
- Increased number and severity of comorbidities
- Longer admission time
- High readmission rate
- High mortality rate

suPAR remained an independent predictor after adjustment for age, sex, Charlson score, and CRP.

Please find the poster on Lines abstract here

Line J.H.Rasmussen at DEMC7

Line Jee Hartmann Rasmussen on the right with her diploma.

Archive

Contact us

virogates logo2
Blokken 45

3460 Birkerød
Denmark

Phone +45 21 13 13 36
Skype: virogates
CVR No.: 25734033
E-mail: info@virogates.com

 in-2  tw-2